Dafna Capital Management LLC Bio N Tech Se Transaction History
Dafna Capital Management LLC
- $331 Million
- Q1 2025
A detailed history of Dafna Capital Management LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Dafna Capital Management LLC holds 10,500 shares of BNTX stock, worth $1.08 Million. This represents 0.29% of its overall portfolio holdings.
Number of Shares
10,500
Previous 8,500
23.53%
Holding current value
$1.08 Million
Previous $968,000
1.24%
% of portfolio
0.29%
Previous 0.26%
Shares
3 transactions
Others Institutions Holding BNTX
# of Institutions
341Shares Held
40MCall Options Held
1.43MPut Options Held
1.54M-
Baillie Gifford & CO8.16MShares$841 Million0.67% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.26MShares$439 Million1.71% of portfolio
-
Primecap Management CO Pasadena, CA4.05MShares$417 Million0.31% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$195 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$186 Million0.84% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $25B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...